Analyst Research

Report Title Price
Provider: Sadif Analytics Prime
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

IntegraGen shares rise sharply on news of collaboration deal with Pfizer-Reuters


Wednesday, 2 Apr 2014 08:00pm EDT 

IntegraGen SA:Shares rise sharply following news of collaboration agreement with Pfizer-Reuters.Agreement with Pfizer to evaluate IntegraGen's hepatocellular carcinoma molecular signature. 

Company Quote

4.8
-0.06 -1.23%
24 Oct 2014